financetom
Business
financetom
/
Business
/
Renovaro Signs Letter of Intent to Acquire Predictive Oncology via All-Stock Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Renovaro Signs Letter of Intent to Acquire Predictive Oncology via All-Stock Deal
Jan 6, 2025 7:21 AM

09:48 AM EST, 01/06/2025 (MT Newswires) -- Renovaro ( RENB ) signed a binding letter of intent to acquire Predictive Oncology ( POAI ) , the companies said Monday.

Under the terms of the agreement, Predictive Oncology ( POAI ) will merge into Renovaro ( RENB ) in exchange for a newly created series of Renovaro ( RENB ) preferred stock, Predictive Oncology ( POAI ) said.

The company said the parties are looking to enter definitive documentation for the merger by no later than Feb. 28.

Renovaro ( RENB ) shares were up 12% while POAI shares were due off halt at 9:50 am ET.

Price: 1.21, Change: +0.28, Percent Change: +30.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Meta expands hate speech policy to remove more posts targeting 'Zionists'
Meta expands hate speech policy to remove more posts targeting 'Zionists'
Jul 9, 2024
(Reuters) - Meta Platforms ( META ) said on Tuesday it would start taking down more posts that target Zionists, where the term is used to refer to Jewish people and Israelis rather than representing supporters of the political movement. The Facebook and Instagram parent said in a blog post it would remove content attacking 'Zionists' when it is not...
CalciMedica Says First Person Dosed in Phase 2 Trial of Auxora to Treat Acute Kidney Injury
CalciMedica Says First Person Dosed in Phase 2 Trial of Auxora to Treat Acute Kidney Injury
Jul 9, 2024
10:45 AM EDT, 07/09/2024 (MT Newswires) -- CalciMedica ( CALC ) said Tuesday the first person has been dosed in its phase 2 trial assessing Auxora to treat severe acute kidney injury with associated acute hypoxemic respiratory failure. The trial is expected to enroll about 150 people, the company said. Topline results -- the number of days alive without need...
Beauty & Wellness Woes: Helen Of Troy's Stock Dives After Disappointing Q1 And Gloomy Forecast
Beauty & Wellness Woes: Helen Of Troy's Stock Dives After Disappointing Q1 And Gloomy Forecast
Jul 9, 2024
Helen Of Troy Ltd ( HELE ) shares are plunging after the company reported worse-than-expected first-quarter FY25 earnings and lowered the outlook. The company reported a first-quarter sales decline of 12.2% year-on-year to $416.85 million, missing the analyst consensus estimate of $445.85 million. The decrease in sales was primarily driven by a decline in sales of hair appliances, prestige hair...
Zomedica Picks Leader Healthcare as Distribution Partner for Products in India, Other Countries
Zomedica Picks Leader Healthcare as Distribution Partner for Products in India, Other Countries
Jul 9, 2024
10:47 AM EDT, 07/09/2024 (MT Newswires) -- Zomedica ( ZOM ) said Tuesday it formed a partnership with Leader Healthcare Group to launch its products in countries including the United Arab Emirates, Saudi Arabia, Qatar, Oman, Kuwait, Bahrain, Egypt and India. The veterinary health company said Leader Healthcare will be the exclusive distributor of its products to veterinarians in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved